| abstract |
To inhibit scarring that occurs when the device is placed in an animal, an electrical device that contacts the tissue (eg, cardiac rhythm management and neurostimulator) is used to prevent scarring (eg, cell cycle inhibitor) Used in combination. The present invention discloses pharmaceutical agents that inhibit one or more aspects of the formation of excess fibrous (scar) or glial tissue. In one aspect, the present invention provides compositions for delivering selected therapeutic agents via medical implants or implantable electromedical devices, as well as methods for making and using the implants and devices. . |